JAMES HEALY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES HEALY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES HEALY. JAMES HEALY is Director in AMARIN CORP PLC\UK ($AMRN) and Director in KALOBIOS PHARMACEUTICALS INC ($KBIO) and Director in Anthera Pharmaceuticals Inc ($ANTH) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Durata Therapeutics, Inc. ($DRTX).
Latest Insider Trading Transactions of JAMES HEALY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, ANTH, DRTX, KBIO, HPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 06 2014 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Sell | S | 27.70 | 417,747 | 11,571,592 | 1,939,474 | 2.4 M to 1.9 M (-17.72 %) |
| May 29 2014 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | A | 26.97 | 4,869 | 131,317 | 4,869 | |
| May 29 2014 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Grant | A | 0.00 | 2,617 | 0 | 14,472 | 11.9 K to 14.5 K (+22.08 %) |
| Mar 05 2014 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Sell | S | 30.02 | 23,625 | 709,223 | 0 | 23.6 K to 0 (-100.00 %) |
| Mar 05 2014 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | J | 0.00 | 23,625 | 0 | 23,625 | 0 to 23.6 K |
| Mar 05 2014 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Sell | J | 0.00 | 590,000 | 0 | 2,357,221 | 2.9 M to 2.4 M (-20.02 %) |
| Mar 13 2014 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
| Mar 13 2014 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 1.87 | 28,500 | 53,295 | 28,500 | |
| Jul 11 2013 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 5.58 | 13,500 | 75,330 | 13,500 | |
| Jul 11 2013 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| May 02 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | A | 6.00 | 15,000 | 90,000 | 15,000 | |
| May 01 2013 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | A | 24.46 | 9,800 | 239,708 | 9,800 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,207 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 80,731 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 643 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 2,565 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 171,450 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,367 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 3,143 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 210,056 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,675 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 9,982 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 653,356 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 19,120 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 5,231 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 341,236 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 11,226 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 2,851 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 185,996 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 6,118 | 0 | 0 | |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,392 | 0 | 31,415 | 30 K to 31.4 K (+4.64 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 93,129 | 0 | 2,072,914 | 2 M to 2.1 M (+4.70 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 742 | 0 | 43,767 | 43 K to 43.8 K (+1.72 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 2,918 | 0 | 30,023 | 27.1 K to 30 K (+10.77 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 195,088 | 0 | 1,979,785 | 1.8 M to 2 M (+10.93 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,555 | 0 | 43,025 | 41.5 K to 43 K (+3.75 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 3,440 | 0 | 27,105 | 23.7 K to 27.1 K (+14.54 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 229,904 | 0 | 1,784,697 | 1.6 M to 1.8 M (+14.79 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,833 | 0 | 41,470 | 39.6 K to 41.5 K (+4.62 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 9,982 | 0 | 23,665 | 13.7 K to 23.7 K (+72.95 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 653,356 | 0 | 1,554,793 | 901.4 K to 1.6 M (+72.48 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 19,120 | 0 | 39,637 | 20.5 K to 39.6 K (+93.19 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 5,231 | 0 | 13,683 | 8.5 K to 13.7 K (+61.89 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 341,236 | 0 | 901,437 | 560.2 K to 901.4 K (+60.91 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 11,226 | 0 | 20,517 | 9.3 K to 20.5 K (+120.83 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 2,851 | 0 | 8,452 | 5.6 K to 8.5 K (+50.90 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 185,996 | 0 | 560,201 | 374.2 K to 560.2 K (+49.70 %) |
| Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 6,118 | 0 | 9,291 | 3.2 K to 9.3 K (+192.81 %) |
| Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | P | 8.00 | 5,485 | 43,880 | 5,601 | 116 to 5.6 K (+4,728.45 %) |
| Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | P | 8.00 | 366,592 | 2,932,736 | 374,205 | 7.6 K to 374.2 K (+4,815.34 %) |
| Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | P | 8.00 | 2,923 | 23,384 | 3,173 | 250 to 3.2 K (+1,169.20 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 2,043 | 0 | 0 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | J | 0.00 | 51,744 | 0 | 2,043 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | X | 0.00 | 53,787 | 0 | 53,787 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | X | 9.62 | 53,787 | 517,431 | 0 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 2,043 | 0 | 0 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | J | 0.00 | 51,744 | 0 | 2,043 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | X | 0.00 | 53,787 | 0 | 53,787 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | X | 9.62 | 53,787 | 517,431 | 0 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | X | 4.08 | 125,291 | 511,187 | 0 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 898,808 | 0 | 0 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 611,185 | 0 | 0 | |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | P | 10.00 | 563,000 | 5,630,000 | 2,947,221 | 2.4 M to 2.9 M (+23.61 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | C | 0.00 | 177,481 | 0 | 2,384,221 | 2.2 M to 2.4 M (+8.04 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | C | 0.00 | 180,459 | 0 | 2,206,740 | 2 M to 2.2 M (+8.91 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | C | 0.00 | 434,096 | 0 | 2,026,281 | 1.6 M to 2 M (+27.26 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | C | 0.00 | 2,043 | 0 | 1,592,185 | 1.6 M to 1.6 M (+0.13 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | C | 0.00 | 2,043 | 0 | 1,590,142 | 1.6 M to 1.6 M (+0.13 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Sell | J | 0.00 | 51,119 | 0 | 1,588,099 | 1.6 M to 1.6 M (-3.12 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | X | 0.00 | 125,291 | 0 | 1,639,218 | 1.5 M to 1.6 M (+8.28 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | C | 0.00 | 898,808 | 0 | 1,513,927 | 615.1 K to 1.5 M (+146.12 %) |
| Aug 02 2012 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Buy | C | 0.00 | 611,185 | 0 | 615,119 | 3.9 K to 615.1 K (+15,535.97 %) |
| Jul 25 2012 | DRTX | Durata Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,683,094 | 0 | 0 | |
| Jul 25 2012 | DRTX | Durata Therapeutic ... | HEALY JAMES | Director | Buy | P | 9.00 | 588,236 | 5,294,124 | 2,271,330 | 1.7 M to 2.3 M (+34.95 %) |
| Jul 25 2012 | DRTX | Durata Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,683,094 | 0 | 1,683,094 | 0 to 1.7 M |
| Sep 05 2012 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | M | 1.03 | 30,000 | 30,900 | 30,000 | |
| Sep 05 2012 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Buy | M | 1.03 | 30,000 | 30,900 | 90,000 | 60 K to 90 K (+50.00 %) |
| Aug 15 2012 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | X | 1.50 | 808,200 | 1,212,300 | 0 | |
| Aug 15 2012 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Buy | X | 1.50 | 808,200 | 1,212,300 | 6,321,588 | 5.5 M to 6.3 M (+14.66 %) |
| Jan 31 2012 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Option Exercise | M | 4.19 | 12,000 | 50,280 | 0 | |
| Jan 31 2012 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | M | 4.19 | 12,000 | 50,280 | 32,443 | 44.4 K to 32.4 K (-27.00 %) |
| Jan 03 2012 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.23 | 280 | 1,743 | 44,969 | 45.2 K to 45 K (-0.62 %) |
| Jan 03 2012 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.23 | 4,090 | 25,460 | 653,550 | 657.6 K to 653.6 K (-0.62 %) |
| Jan 03 2012 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.23 | 20,630 | 128,422 | 3,298,684 | 3.3 M to 3.3 M (-0.62 %) |
| Jan 31 2012 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | M | 1.03 | 60,000 | 61,800 | 60,000 | |
| Jan 31 2012 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Buy | M | 1.03 | 60,000 | 61,800 | 60,000 | 0 to 60 K |
| Dec 23 2011 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.22 | 280 | 1,743 | 45,249 | 45.5 K to 45.2 K (-0.61 %) |
| Dec 23 2011 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.22 | 4,090 | 25,457 | 657,640 | 661.7 K to 657.6 K (-0.62 %) |
| Dec 23 2011 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.22 | 20,630 | 128,405 | 3,319,314 | 3.3 M to 3.3 M (-0.62 %) |
| Dec 23 2011 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.51 | 280 | 1,823 | 45,529 | 45.8 K to 45.5 K (-0.61 %) |
| Dec 23 2011 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.51 | 4,090 | 26,629 | 661,730 | 665.8 K to 661.7 K (-0.61 %) |
| Dec 23 2011 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Director | Sell | S | 6.51 | 20,630 | 134,318 | 3,339,944 | 3.4 M to 3.3 M (-0.61 %) |
Page: 1